Merck & Co., Inc. (FRA:6MK)
69.30
-2.20 (-3.08%)
Last updated: May 13, 2025
Merck & Co. Revenue
Merck & Co. had revenue of $15.53B USD in the quarter ending March 31, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to $63.92B, up 4.10% year-over-year. In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth.
Revenue (ttm)
$63.92B
Revenue Growth
+4.10%
P/S Ratio
3.07
Revenue / Employee
$852.29K
Employees
75,000
Market Cap
181.62B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.17B | 4.05B | 6.74% |
Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Siemens Healthineers AG | 23.14B |
Merck & Co. News
- 8 hours ago - Tech sector leads: Nvidia and Amazon surge amidst healthcare tumble - Forexlive
- 12 hours ago - Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025 - Wallstreet:Online
- 12 hours ago - Research on Novel Treatment Approaches and Scientific Advances From Merck's Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025 - Business Wire
- 1 day ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 1 day ago - Drugmakers are spared worst-case drug pricing scenario for now - WSJ
- 1 day ago - Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more - CNBC
- 1 day ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 1 day ago - Trump says executive order will slash the cost of prescription drugs - Business Insider